REQUEST A DEMO
Total
USD $0.00
Search more companies

Nepentes Pharma Sp. z o.o. (Poland)

Main Activities: Advertising Agencies
Full name: Nepentes Pharma Sp. z o.o. Profile Updated: March 17, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Nepentes Pharma Sp. z o.o. is a company in Poland, with a head office in Warsaw. It operates in the Advertising Agencies industry. The enterprise was incorporated on December 31, 2010. It currently has a total number of 2 (2020) employees. In 2020, the company reported a net sales revenue drop of 54.05%. Over the same period, its total assets grew by 74.89%. The net profit margin of Nepentes Pharma Sp. z o.o. increased by 425.35% in 2020.

Headquarters
Ul. Bonifraterska 17
Warsaw; Mazowieckie; Postal Code: 00-203

Contact Details: Purchase the Nepentes Pharma Sp. z o.o. report to view the information.

Website: http://www.nepentes.pl

Basic Information
Total Employees:
Purchase the Nepentes Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Nepentes Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Nepentes Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Nepentes Pharma Sp. z o.o. report to view the information.
Incorporation Date:
December 31, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Nepentes Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-54.05%
Total operating revenue
190.09%
Operating profit (EBIT)
1655.15%
EBITDA
914.12%
Net Profit (Loss) for the Period
1368.79%
Total assets
74.89%
Total equity
70.91%
Operating Profit Margin (ROS)
523.57%
Net Profit Margin
425.35%
Return on Equity (ROE)
36.66%
Quick Ratio
-3.21%
Cash Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?